9 February 2026: NIFTY 50 Ends Near Day’s High at 25,867 as SBI, Shriram Finance Lead; Defensive & Energy Stocks Lag

Mumbai, 09 February 2026 (15:30 IST) — Indian equities closed Monday’s session on a firm footing, with the NIFTY 50 finishing near the day’s peak, supported by strong buying in banking and financial stocks. Heavyweights such as State Bank of India (SBI) and Shriram Finance powered the rally, while selective selling in healthcare, energy, and FMCG capped broader upside.

Also Read: 9 February 2026 (mid-cap): NIFTY 50 Holds Gains Near 25,850 as SBI, Shriram Finance Power Rally; IT & FMCG See Profit-Taking

📊 Benchmarks Close Strong, Financials Outperform

The NIFTY 50 settled at 25,867.30, up 173.60 points (+0.68%). The index opened at 25,888.70, touched an intraday high of 25,922.25, and dipped to a low of 25,780.90 before recovering into the close, signaling sustained buying interest at lower levels.

Broader market indicators remained supportive, with NIFTY Next 50 gaining 0.97%, NIFTY Financial Services rising 1.25%, and NIFTY Bank advancing 0.91%, reinforcing the leadership of financial and cyclical stocks.

🏦 Banks, NBFCs and Industrials Drive the Rally

The session’s gains were led by strong performances in large-cap banks, NBFCs, and select industrial names:

• State Bank of India (SBI) jumped 7.63% to ₹1,147.80, with massive volumes of over 408 lakh shares and turnover exceeding ₹4,600 crore, underlining strong institutional participation.

• Shriram Finance surged 6.03% to ₹1,063.00, extending momentum in the NBFC space.

• Grasim Industries added 3.11% to ₹2,925.00, continuing the positive trend in diversified industrial stocks.

• Titan Company climbed 3.04% to ₹4,267.00, reflecting steady buying interest in discretionary consumption plays.

• Dr Reddy’s Laboratories gained 2.80% to ₹1,276.00, offering support from the pharma space.

The strong showing in these stocks helped the benchmark index close near the day’s highs despite pockets of weakness elsewhere.

📉 Healthcare, Energy and FMCG Stocks Under Pressure

On the flip side, several frontline names witnessed profit-taking and mild selling pressure:

• Max Healthcare declined 2.82% to ₹1,010.50, emerging as the top laggard of the session.

• NTPC slipped 1.05% to ₹361.20, while ONGC eased 0.84% to ₹266.70, reflecting softness in the energy pack.

• ITC fell 0.95% to ₹322.70, indicating continued consolidation in FMCG heavyweights.

• ICICI Bank ended 0.78% lower at ₹1,395.10, showing stock-specific profit-taking despite overall strength in the banking sector.

This divergence highlights ongoing sectoral rotation, with investors favoring select financials and cyclicals over defensives.

🧠 Market View: Uptrend Intact, Stock-Specific Action Dominates

Market participants noted that the indices are holding firm at elevated levels, with dips being bought into, particularly in banks and NBFCs. The strong volume-driven rally in SBI and Shriram Finance suggests confidence in the financial sector’s earnings outlook. At the same time, caution in healthcare, FMCG, and energy stocks points to a more selective, stock-by-stock approach by investors.

📌 Conclusion: 9 February 2026

The Indian equity market closed the day with a constructive tone, as the NIFTY 50 ended near 25,867, supported by robust gains in banking and financial stocks. While weakness in select defensives and energy names limited broader participation, the overall structure of the market remains positive, with investors continuing to rotate towards high-beta and cyclical opportunities. Near-term direction is likely to be guided by global cues, macroeconomic data, and upcoming corporate developments.